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Atopic dermatitis (AD), is known to have chronic inflammatory 
symptoms in the skin. It induces disorder in the skin and initiates the 
allergic march including allergic rhinitis and asthma in the early life of a 
human. Probiotic Lactobacillus is reported to prevent the symptoms of 
the allergic diseases. There have been no reported vaginal Lactobacillus 
spp. associated with allergic diseases. To examine the possible anti-
allergic effects of vaginal Lactobacillus spp., RBL-2H3 cells, EL4 cells, 
U266B1 cells and RAW 264.7 cells were used in this study. Several 
vaginal Lactobacillus strains including L.crispatus, L.gasseri, L.jensenii, 
and L.sakei were shown to inhibit the degranulation of basophil. 
Increased IgE level, which is key pathogenesis of the atopic disease, was 
found to be alleviated in U266B1 cell co-cultured with vaginal 
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L.crispatus, L.jensenii and L.sakei strains. Several strains of vaginal 
L.crispatus, L.gasseri, and L.jensenii prevented secretion of Th2 type 
cytokines including IL-4, IL-5 which mediate allergic response. Through 
determining the ratio of IL-10 to TNF-α and IL-10 to IL-6, the anti-
inflammation capacity of vaginal Lactobacillus strains was measured. 
L.crispatus species were shown to have the highest anti-inflammatory 
capacity. To test in vivo therapeutic effects of vaginal Lactobacillus spp. 
on atopic dermatitis, NC/Nga mouse model was used. In the mice treated 
with vaginal Lactobacillus crispatus SNUV206, dermatitis score and 
scratching time were significantly decreased compared to the mice 
treated with PBS. Ear and dorsal skin thickness which are thickened in 
atopic dermatitis patients are also alleviated in SNUV206 treated mice. 
In conclusion, SNUV206 may have potential therapeutic effects on 
atopic dermatitis. 
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Atopic dermatitis (AD) represents an allergic inflammatory disease 
and is often the first disease present in a series of allergic diseases[1]. 
AD has increased in prevalence over the past several decades, 
particularly in developed countries[2]. During the early stage of allergy, 
antigens processed by antigen presenting cells (APC) activates T helper 
cells (Th cell), expressing Th2 type cytokines such as interleukin (IL)-4, 
IL-5 and IL-13[3][4]. Especially, IL-4 plays important role in switching 
immunoglobulin E (IgE) production in B cells[5][6]. Produced IgE 
reaches to the mast cells or basophil in tissue or blood and binds to the 
FcεRI to stimulate degranulation of the cells[7][8]. As a result of 
degranulation, pro-inflammatory compounds such as histamine, 
cytokines, and chemokines are released[9][7]. These molecules cause the 
symptoms of AD, the recruitment of inflammatory cells. Macrophage, 
which plays a critical role in innate immunity and also helps initiate 
adaptive immunity, can secrete various cytokines that promote and 
inhibit the inflammation. Representative pro-inflammatory cytokines are 
tumor necrosis factor α (TNF- α) and IL-6, and anti-inflammatory 
cytokine IL-10 is the key cytokine which can balance the Th1 and Th2 
immune response[10].  
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Although the cause and mechanism of AD are not fully understood, 
antihistamine and corticosteroid treatment are used as therapies for AD-
induced inflammation[11]. However, it has been previously shown that 
reduced diversity of the intestinal microbiota in infants is associated with 
increased risk of AD[12][13]. As a result, bacterial exposure has been 
suggested as a key factor in atopic diseases, potentially through intestinal 
colonization and immunomodulation[14]. Several trials have evaluated 
the role of probiotics in the prevention of atopic diseases and atopic 
sensitization, and there is compelling evidence for the effect on 
AD[15][16]. Furthermore, the mode of delivery (especially Cesarean 
section delivery) are reported to be associated with allergic disease 
incidence rate after birth as well as AD[17][18]. Therefore, it is assumed 
that microbial exposure through maternal vaginal microbiome during 
birth process may have a beneficial effect on the development of the 
immune system of infants in early life[19].  
Thus, the objective of this research is to test the anti-allergic capability 
of Lactobacillus spp. originated from the vagina. To achieve this aim, in 
this study, we used several in vitro system which can evaluate the 
inhibitory effect of vaginal Lactobacillus spp. on degranulation, IgE 
secretion, Th2 cytokines production, and anti-inflammatory response. 
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We also used DNCB-induced NC/Nga murine model to investigate its 











II. Materials and Methods 
In vitro study   
1. Lactobacillus spp. culture and preparation  
The Lactobacillus strains isolated form human vagina and gut were used 
in this study (Table 1). The vaginal samples were obtained from three 
Korean women consisting of a monozygotic twin pair and their mother. 
The Strains originated from gut were isolated from fecal samples of 
Korean Population. All isolates were identified to the species level by 
sequencing of 16s rRNA. Lactobacillus spp. were cultured anaerobically 
in MRS broth (Thermo Fisher Scientific, USA) with 0.05% L-cysteine 
hydrochloride (Sigma-Aldrich, USA) for 18 h at 37℃. After being 
subcultured twice (1% v/v) from the stock, the bacterial cells were 
harvested in a centrifuge (4℃, 1500rpm, 3min) and washed twice with 
PBS. The number of bacteria was counted by Baclight Live/Dead 
Bacterial Viability Kit (Molecular Probes, USA) using an Accuri C6 flow 





















































































Lactobacillus vaginalis SNUV351 1  - 
Total  21  2 
Twenty-one vaginal Lactobacillus strains and two Lactobacillus strains 
isolated from the gut were used in this study. 
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2. Cell line culture 
RBL-2H3 rat basophil cell line (KCLB No. 22256), EL4 mouse T 
lymphoma cell line (KCLB No. 40039) and RAW 264.7 mouse 
macrophage cell line (KCLB No. 40071) were purchased from the 
Korean Cell Line Bank (KCLB, Seoul, Korea). U266B1 human B 
lymphoma cell line (ATCC® TIB 196™) was obtained from Korea 
Centers for Disease Control and Prevention (Ochang, Korea). RBL-2H3 
cells, EL4 cells, and RAW 264.7 cells were cultured in DMEM medium 
(Gibco, USA) supplemented with 10% inactivated FBS, 100 IU/ml 
penicillin-streptomycin in 37℃ under 5% CO2. U266B1 cells were 
cultured in RPMI-1640 medium (Gibco, USA) supplemented with 10% 











3. β-hexosaminidase secretion assay 
RBL-2H3 cells were seeded in 6-well plates (1×106 cells/well). Three 
hours after seeding, the cells were sensitized with 0.5μg/ml DNP-
specific IgE (Sigma-Aldrich, USA), and incubated overnight. After the 
cells were washed with siraganian buffer (119mM NaCl, 5mM KCl, 
0.4mM MgCl2, 25mM PIPES, 40mM NaOH, pH7.2) twice, they were 
exposed to the Lactobacillus spp. (1 × 109 cells/well) or ketotifen 
(20μg/ml) and incubated 37℃ for 20min. After incubation, the cells were 
stimulated with 1μg/mL of dinitrophenyl-human serum albumin (DNP-
HSA) for 37℃ 10 min. The reaction was terminated by placing the plates 
on ice. The cell culture supernatant was collected to determine the level 
of IL-4 by ELISA (BD Biosciences, USA). 25μl of cell culture 
supernatant was incubated with an equal volume of 1mM substrate 
solution (1mM p-nitrophenyl-N-acetyl-β-D-glucosaminide) dissolved in 
0.1 M citrate buffer, pH 4.5) at 37 °C for 90 min. Then, the enzyme 
reaction was terminated by adding 200μl of stop solution (0.1 M 
Na2CO3/NaHCO3, pH 10.0). Finally, absorbance was measured at 405 





4. Cytokine production assay  
To measure the IL-4 and IL-5 inhibition effect of Lactobacillus spp. 
isolated from the vagina, EL4 cells were seeded in 24-well plates (5×104 
cells/well) and incubated 37℃ overnight. EL4 cells were stimulated by 
20ng/ml PMA (Sigma-Aldrich, USA) and 1μg/ml Ionomycin (Sigma-
Aldrich, USA), and the Lactobacillus strains (5× 105 cells/well) were 
added to the cells. After 24h, the supernatant was collected for measuring 
the level of IL-4 and IL-5 by ELISA (BD Biosciences, USA). To measure 
the effect on TNF-α, IL-6, and IL-10 of Lactobacillus spp. isolated from 
the vagina, RAW 264.7 cells were seeded in 24-well plates (1× 105 
cells/well) and incubated 37℃ overnight. RAW 264.7 cells were 
stimulated by 100ng/ml lipopolysaccharide (LPS, Sigma-Aldrich, USA), 
and the Lactobacillus strains (1×106 cells/well) were added to the cells. 
After 24h, the supernatant was collected for measuring the level of TNF-








5. IgE production assay 
The IgE-inhibitory effects of Lactobacillus spp. isolated from the vagina 
in human B cells were measured by the following method. U266B1 cells 
were seeded in 24-well plates (1× 105 cells/well) and incubated 37℃ 
overnight. U266B1 cells were stimulated by 50ng/ml IL-4 (Sigma-
Aldrich, USA) and 100μg/ml LPS (Sigma-Aldrich, USA), and the 
Lactobacillus strains (1×106 cells/well) were added to the cells. After 
48h, the IgE in supernatants was detected by using human IgE ELISA 














In vivo study   
6. Animals 
Female NC/Nga mice (6 weeks old) were obtained from SLC Japan 
(Shizuoka, Japan). The mice were maintained on a 12 hours light/dark 
cycle with lights on at 9 a.m. 5 mice per group were used in all 
experiments. All the experimental procedures were approved by Seoul 
National University Institution Animal Care and Use Committees 
(IACUC).  
7. Murine atopic dermatitis model 
The dorsal hair of all mice was shaved by electric shaver prior to atopic 
dermatitis-like skin lesion induction. 1-chloro-2,4-dinitrobenzene 
(DNCB) was used as an AD inducer. In brief, 1% DNCB solution was 
freshly made in acetone : olive oil (3 : 1), and applied on the shaved area 
of dorsal skin of the mice twice a week from day 0 to end of the 
experiment. Five groups (DNCB/Lactobacillus spp.) of mice were 
administrated with Lactobacillus spp. at 1×109 CFU/200ul/day by oral 
gavage from day 22 to day 56, while the negative control group 
(DNCB/PBS) of mice was fed with 200μl of PBS. As a naïve control, 
mice without DNCB treatment were maintained by being fed with 200μl 
of PBS (Fig. 1). At the end of the experiment, ear thickness was measured 
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Figure 1. Experimental procedure of murine atopic dermatitis model 
Experimental design. NC/Nga mice were divided into seven groups: (1) naïve, (2) DNCB treat (negative), (3) DNCB + SNUV195, (4) DNCB 
+ SNUV8, (5) DNCB + SNUV206, (6) DNCB + SNUG375, (7) DNCB + SNUG134 (n=5 per group). To study the effect of vaginal 
Lactobacillus spp. in atopic dermatitis, mice were treated with DNCB for 8 weeks, and PBS or Lactobacillus was fed by oral gavage for 5 
weeks from day 21. , topical DNCB treatment. 
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8. Evaluation of dermatitis score  
The severity of dermatitis score was evaluated before sacrifice. Scores 
of 0 (none), 1 (mild), 2 (moderate), and 3 (severe) were measured for 
each of the four symptoms: 1) erythema/hemorrhage, 2) scarring/dryness, 
3) edema, and 4) excoriation/erosion. The sum of the individual scores 
indicating clinical severity was taken as the dermatitis score. 
9. Evaluation of scratching behavior 
The AD-like behavioral change was evaluated by measuring the time that 
mice spent scratching their nose, ears, and dorsal skin with their paws 
for 20 min on the last day of the experiment (on day 56). 
10. Histological analysis 
To measure the skin thickening, the dorsal skin of each mouse was 
excised on day 56, fixed with neutral buffered formalin, and embedded 
in paraffin. The skin sections were cut from the blocks at 5μm thickness. 
After staining with hematoxylin and eosin (H&E), the epidermal 
thickness was observed under a microscope at 40× magnification.  
11. Flow cytometry 
To investigate the immune response of AD-induced NC/Nga mice treated 
with Lactobacillus spp., mesenteric lymph node (MLN) of the mice were 
excised and minced into single cell suspension passing through a 20-μm 
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cell strainer (Celltrix). Suspended cells were centrifuged at 1500rpm for 
5 min. The pellet was resuspended in fluorescence-activated cell sorting 
(FACS) buffer (2 mM EDTA, 2% fetal bovine serum in PBS). The cells 
were then incubated with labeled monoclonal antibodies (eBioscience) 
and analyzed by flow cytometry using a FACSverse flow cytometer 
(Becton Dickinson). Data were analyzed with FlowJo software (Tree Star, 
Inc). We validated the flow cytometric identification of CD3+ (T cells), 
B220+ (B cells), CD3+CD4+ (T helper cells), and CD3+CD4+CD25+ 
(activated T cells) among mesenteric lymph node cells as previously 
described.[20] 
12. Statistical analysis 
All data were analyzed with Prism 5 (GraphPad Software, CA). 
Statistical significance was measured using Mann-Whitney test when 
comparing two groups, two-way ANOVA with Bonferroni post-test 








III. Results  
1. Effect of Lactobacillus spp. isolated from the vagina on β-
hexosaminidase release in RBL-2H3 cells 
β-hexosaminidase is a well-established degranulation marker resulting 
from the allergic response of RBL-2H3 cells[21]. The inhibitory effect 
of Lactobacillus spp. isolated from the vagina on β-hexosaminidase 
secretion was examined. Through primary screening of 49 Lactobacillus 
strains isolated from the vagina, 17 strains which had stronger inhibitory 
effects compared to ketotifen and 4 strains which had no inhibitory effect  
were selected (Fig. S1). After three independent sets of experiments, β-
hexosaminidase secretion was significantly lower in RBL-2H3 cells 
treated with 17 Lactobacillus strains isolated from the vagina (Fig. 2). 
Ketotifen (20μg/ml) was also shown to significantly reduce β-
hexosaminidase secretion induced by DNP-HSA. Some Lactobacillus 
species such as L. crispatus, L. gasseri, L. jensenii and L. sakei showed 





Figure 2. Effect of Lactobacillus spp. isolated from the vagina on β-hexosaminidase release in RBL-2H3 cells 
Rat RBL-2H3 cells were cultured with Lactobacillus spp. for 20min. β-hexosaminidase release in the duplicate microplate wells was 
determined by colorimetric method. (A) Strain- and (B) species-specific effects of Lactobacillus spp. isolated from the vagina on β-
hexosaminidase release in RBL-2H3 cells. The whiskers of each boxplot represent the 10 to 90 percentiles. Three independent sets of 
experiments were performed in each case. * P < 0.05, ** P<0.01, *** P < 0.001. 
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2. Effect of Lactobacillus spp. isolated from the vagina on the 
level of IgE secretion in U266B1 cells 
To evaluate the effect of Lactobacillus spp. isolated from the vagina on 
IgE production in B lymphocytes, we selected 14 vaginal Lactobacillus 
strains which have consistent and repeatable inhibition capability in β-
hexosaminidase release assay. U266B1 cells were stimulated with LPS 
and IL-4. Five strains of L. crispatus and two strains of L. sakei used in 
this study significantly inhibited the production of IgE and one strain of 











Figure 3. Effect of Lactobacillus spp. isolated from the vagina on the level of IgE secretion in U266B1 cells 
Human U266B1 B cells were stimulated with LPS and IL-4 co-cultured with Lactobacillus spp. isolated from the vagina. After 48 hours, the 
level of secreted IgE was measured with an ELISA kit. (A) Strain- and (B) species-specific effects of Lactobacillus spp. isolated from the 




3. Effect of Lactobacillus spp. isolated from the vagina on 
cytokine secretion in cell lines  
To better understand the effect of Lactobacillus spp. isolated from the 
vagina on immune cell signaling, level of 5 cytokines were measured in 
the supernatant of cells co-cultured with Lactobacillus spp. isolated from 
the vagina. First, the IL-4 level was shown to decrease in comparison 
with the control in RBL-2H3 cell line in response to treatment with 
several strains of L. crispatus, L. gasseri, L. jensenii and L. sakei. Second, 
6 strains of L. crispatus and 1 strains of L. jensenii showed significant 
suppressive activity on the production of IL-4, 7 strains of L. crispatus 
and 1 strains of L. gasseri and L. jensenii significantly inhibited the 
secretion of IL-5 in EL4 cell line. Lastly, the pro-inflammatory cytokines 
TNF-α, IL-6 and anti-inflammatory cytokine IL-10 were measured in 
Raw 264.7 cell line co-cultured with Lactobacillus spp. isolated from the 
vagina. Then the ratio of IL-10/TNF-α and IL-10/IL-6 were evaluated to 
determine anti-inflammatory effects of Lactobacillus spp. isolated from 
the vagina. All strains showed anti-inflammatory effect, but L. crispatus 






Figure 4. Effect of Lactobacillus spp. isolated from the vagina on the level of IL-4 in RBL-2H3 cells 
Rat RBL-2H3 cells were cultured with Lactobacillus spp. isolated from the vagina for 24 h. The supernatant level of IL-4 was determined 
by ELISA kit. The whiskers of each boxplot represent the 10 to 90 percentiles. Three independent sets of experiments were performed in 




Figure 5. Effect of Lactobacillus spp. isolated from the vagina on the level of IL-4 and IL-5 in EL4 cells 
EL4 cells were cultured with Lactobacillus spp. for 24 h. The supernatant level of IL-4 and IL-5 in the duplicate microplate wells were 
determined by ELISA kit. Several strains of Lactobacillus spp. isolated from the vagina effect on the supernatant (A) IL-4 and (C) IL-5 level 
in EL4 cells. Values are shown as mean±SD. Species-specific effect of Lactobacillus spp. isolated from the vagina on (B) IL-4 and (D) IL-5 
secretion level in EL4 cells. The whiskers of each boxplot represent the 10 to 90 percentiles. Three independent sets of experiments were 






Figure 6. Effect of Lactobacillus spp. isolated from the vagina on the level of TNF- α, IL-6 and IL-10 in RAW 264.7 cells 
RAW 264.7 cells were cultured with Lactobacillus spp. for 24 h. The supernatant level of TNF-α, IL-6, and IL-10 in the duplicate microplate 
wells were determined by ELISA kit. Several strains of Lactobacillus spp. isolated from the vagina effect on the supernatant (A) TNF- α (B) 






Figure 7. Effect of Lactobacillus spp. isolated from the vagina on the level of IL-10/ TNF-α and IL-10/IL-6 in RAW 264.7 cells 
RAW 264.7 cells were cultured with Lactobacillus spp. for 24 h. The ratio of IL-10/ TNF-α and IL-10/IL-6 was evaluated. Several strains of 
Lactobacillus spp. isolated from the vagina effect on (A) IL-10/ TNF-α and (C) IL-10/IL-6 ratio in RAW 264.7 cells. Values are shown as 
mean±SD. Species-specific effect of Lactobacillus spp. isolated from the vagina on (B) IL-10/ TNF-α and (D) IL-10/IL-6 ratio in RAW 
264.7 cells. The whiskers of each boxplot represent the 10 to 90 percentiles. Three independent sets of experiments were performed in each 
case. ** P < 0.01, *** P < 0.001. 
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4. Vaginal L. crispatus strain SNUV206 alleviated DNCB-
induced AD-like symptoms in NC/Nga mice 
Through in vitro assays above，we selected 3 vaginal L.crispatus 
strains which showed the most suppressive effect on allergic resp
onse. 2 Lactobacillus strains originated from the human gut are 
also used in this animal study. SNUG375 strain is L.fermentum 
which showed inhibitory effect on AD in the previous study. SN
UG134 strain is L.gasseri which used as a bacteria control. AD-
like skin lesions were induced via the repeated topical application of 
DNCB in NC/Nga mice. A 5-week course of oral treatment of 
Lactobacillus spp. suppressed the development of AD-like skin lesions 
in comparison with the control group (Fig. 8). The dermatitis score of 
AD-like skin lesions between the negative control group and SNUV195, 
SNUV8, SNUG134 groups were not significantly different throughout 
the 6 weeks of treatment (Fig. S3). However, the SNUV206 and 
SNUG375 group showed a significant decrease in dermatitis score 
compared to the negative control group (Fig. 9A). Among groups tested 
in this study, we selected 4 meaningful groups in-depth study. As shown 
in Fig. 9C, the ear thickness of mice treated with SNUV206 was shown 
to be significantly reduced in comparison to those treated with PBS. The 
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scratching behavior of the naïve group was determined to be 4.4±3.2 
seconds in 20 minutes. The score significantly increased in the negative 
group. By contrast, the scratching time of the SNUV206 (21.1±12.4) 
group was significantly lower than those of the negative (103.8±41.9) 
group (Fig. 9B). We compared the change of morphological features of 
the spleen among the groups. The mice receiving PBS and SNUG134 
were found to have significantly enlarged spleens compared to those of 
the control group. However, spleen weight was reduced in mice treated 
with SNUV206 (Fig. 9D). No significant difference in body weight is 
observed among the experimental groups, implying that administration 
of Lactobacillus spp. is physiologically safe to the NC/Nga mice (Fig. 







Figure 8. DNCB-induced AD-like skin lesions in NC/Nga mice 





Figure 9. Effect of Lactobacillus spp. on DNCB-induced AD-like symptoms in NC/Nga mice 
Effect of Lactobacillus spp. on DNCB-induced AD-like symptoms in NC/Nga mice. (A) The dermatitis score of AD-like skin lesions was 
measured concerning erythema/hemorrhage, scaling/dryness, edema, and excoriation/erosion at the end of the study. (B) Scratching behavior 
of mice was observed for 20 min after sensitization. (C) The average of the left and right ear thickness was measured. (D) After sacrifice, the 
spleen was isolated and weighed to examine splenomegaly alteration. Spleen weight-to-body weight ratio was evaluated. Results are 
expressed as the means±SD. * P < 0.05, ** P < 0.01, *** P < 0.001.
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5. Lactobacillus spp. administration decreased skin thickness 
in NC/Nga mice 
Figure 10A shows the changes in the histopathological features of the 
lesions on the dorsal skin of NC/Nga mice. The negative mice had highly 
thickened epidermis, a mean of 719.5μm compared with 432.0μm in 
naïve mice. In comparison with the negative group, SNUV206 and 
SNUG134 received groups showed less thickened epidermis (Fig. 10B). 
Administration of SNUV206 and SNUG134 resulted in epidermal 
thicknesses of 638.9 and 597.8μm, respectively. Furthermore, SNUV206 
treated group tends to be decreased compared to the negative control 
group in the serum IgE level (Fig. S4). Through FACS analysis, 
Lactobacillus spp. administration did not alter the T cell population, B 
cell population, proportion of helper T cell, and cytotoxic T cell in the 
AD-induced mice (Fig. S5). Nevertheless, the number of CD25+ cells in 
the SNUV206 treated mice was downregulated compared to the negative 
group mice while the number of CD25+ cells in the negative group was 
significantly upregulated compared to the naïve group, implying that 
inflammatory tone may attenuate by treatment of SNUV206 to the AD-






Figure 10. Histological changes in skin in AD-affected NC/Nga mice 
(A) Histological features of dorsal skin lesions stained with hematoxylin and eosin (40x). (B) Epidermal thickness according to treatment 




In previous studies, the protective effects of probiotics isolated from the 
gut or food on allergic diseases have been demonstrated[22][23]. 
Recently, it has also been suggested that vaginal Lactobacillus spp. can 
have a probiotic effect [24]. Most studies related to vaginal Lactobacillus 
spp. are focused on vaginal health[25][26]. However, in this study, we 
focused on the capability of Lactobacillus spp. to exert a probiotic effect 
on allergic disease. 21 vaginal Lactobacillus strains previously isolated 
from healthy Korean women were used to test anti-allergic effect in this 
study. Using RBL-2H3 mast cells, EL4 T cells, U266B1 B cells and 
RAW264.7 macrophage cells, we demonstrated that treatment with 
vaginal Lactobacillus strains exerts beneficial effects on allergic 
responses in vitro. Through DNCB-induced NC/Nga mice, we 
demonstrated that oral treatment of a vaginal Lactobacillus strain has an 
inhibitory effect on AD-like skin lesions in vivo.  
Mast cells respond with degranulation following crosslinking of IgE 
bound FcεRI by various allergens, with the release of newly synthesized 
mediators including histamine and cytokines that evoke a potent immune 
allergic response. They can be activated by IgE-dependent mechanisms, 
releasing inflammatory mediators including histamine and cytokines[7]. 
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RBL-2H3 cells are the most commonly used mast cell line which can 
produce β-hexosaminidase in the process of degranulation. 
Degranulation of RBL-2H3 cells, as a consequence of IgE-FcεRI 
stimulation, reflects the behavior of both mast cells and basophils in 
respect of their response to immunological stimuli[27]. In this study, 17 
out of 21 vaginal Lactobacillus strains inhibited the secretion of β-
hexosaminidase in IgE-DNP-stimulated RBL-2H3 cells, which indicated 
the inhibitory activity of vaginal Lactobacillus spp. to mast cell 
degranulation. 
As IgE is a key effector responsible for the progression of allergic 
reactions and contributes to activation of other cell types involved in 
allergic inflammation[28], IL-4- and LPS-stimulated U266B1 cells were 
treated with vaginal Lactobacillus spp. and the secreted IgE level was 
measured. All strains of L. crispatus and L. sakei strains tested in this 
study were shown to diminish IgE secretion. In accordance with this data, 
similar observations of Phellinus linteus extract inhibiting IgE 
production in U266B1 cells have been reported[29]. Still, this is the first 
research to use bacteria to inhibit IgE production in the U266B1 cell line.  
Cytokines are produced by various types of immune cells and Th1 and 
Th2 type cytokines are known to be associated with allergic pathogenesis. 
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Some strains of L. crispatus, L. gasseri, and L. sakei regulated Th2-type 
cytokine production in EL4 T cell line, including IL-4 or IL-5. Pro-
inflammatory cytokines (TNF-α, IL-6) were shown to be elevated in 
RAW 264.7 macrophage cell line after treatment with vaginal 
Lactobacillus spp. The anti-inflammatory cytokine IL-10 is secreted by 
the secretion of pro-inflammatory cytokines, and IL-10 inhibits the 
release of pro-inflammatory cytokines. All vaginal Lactobacillus strains 
promoted the release of IL-10 compared to the media control in RAW 
264.7 cells. The IL-10/TNF-α and IL-10/IL-6 ratio are considered to be 
a good indicator of the anti-inflammatory effect of a probiotic strain[30]. 
The group of L. crispatus showed the highest level compared to the other 
vaginal Lactobacillus species in this study.  
It has been reported that several Lactobacillus strains isolated from the 
gut have inhibitory effects on allergic diseases in animals and 
humans[31][22]. In this study, we used a DNCB-induced NC/Nga mouse 
model to screen for effective vaginal Lactobacillus strains. In order to 
confirm an inhibitory effect on atopic dermatitis, we used SNUG375 
Lactobacillus strains derived from the gut as a positive control and 
SNUG134 Lactobacillus strains derived from the gut as a negative 
control. The result of the dermatitis scores shows that SNUV206 strain 
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has a treatment effect on the atopic dermatitis phenotype that is stronger 
than the positive control, SNUG375. In patients with AD, itch-associated 
scratching results in skin barrier defects and increases inflammation, 
both of which ultimately increase associated itching[32]. The results 
indicate that SNUV206, as well as SNUG375, significantly inhibit 
spontaneous scratching behavior resulting from DNCB treatment, 
suggesting that SNUV206 may exert an anti-allergic effect by reducing 
scratching behavior and preventing the aggravation of skin lesions. In 
the present study, the ear thickness was used as an indicator of edema, 
frequently found in the chronic AD. The ear dermal thickness in 
SNUV206-administered mice was lowered compared to that in mice in 
the PBS control group. It indicates that SNUV206 treatment improves 
the skin condition by decreasing edema and skin deformation.  
The spleen is composed of various immune cells and plays an important 
role in regulating immune responses. As splenomegaly indicates 
abnormality of immune system function in AD[33], we measured the 
ratio of mice spleen and body weight. The DNCB-treated mice 
demonstrated significantly heavier spleens compared to the non-induced 
group. The enlarged spleen effect was found to be alleviated in 
SNUV206-treated mice, but not in SNUG134 treated mice.  
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In conclusion, this research clearly shows that vaginal Lactobacillus 
spp., especially vaginal L. crispatus, have an inhibitory effect on allergy-
related response through in vitro assay. Moreover, vaginal L. crispatus 
SNUV206 treatment significantly improves symptoms of dermatitis in 
NC/Nga mice. These results indicate that SNUV206 has potential 
capability to achieve normal skin in AD-induced NC/Nga mice. Several 
previous studies have reported that the AD-like skin lesions in NC/Nga 
mice are comparable to those of human AD[34]. Therefore, the 
therapeutic effect of vaginal L. crispatus on AD-induced mouse could 
potentially translate to human subjects. SNUV206 is now under 
mechanical study to evaluate its mechanism of inhibitory effect on AD. 
 An effective compound of vaginal L. crispatus SNUV206 was not 
clarified yet due to its multifunctional probiotic properties. It is clear that 
vaginal L. crispatus interacts with several immune responses related to 
an allergic reaction, and its effective bioactivity is reproducible and 
consistent both in vitro and in vivo. So far non-specific treatments such 
as antihistamine and corticosteroid have been commonly used as 
therapies for AD. In this study, we suggest vaginal Lactobacillus strain 
SNUV206 as a specific and safe treatment for AD, to further identify its 
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Supplementary figure 1. Primary screening of Lactobacillus spp. isolated from the vagina inducing β-hexosaminidase release in RBL-
2H3 cells 
49 Lactobacillus strains isolated from the vagina were tested β-hexosaminidase secretion in RBL-2H3 cells. 17 strains had stronger inhibitory 
effects compared to ketotifen which is positive drug control. 4 strains were selected as non-effective strain control (blue arrowheads, effective 





Supplementary figure 2. Body weight among the mice of experimental groups 
 
No significant difference in body weight is observed among the experimental groups 
(N=5 per group), implying that administration of Lactobacillus spp. is physiologically 





Supplementary figure 3. The dermatitis score changes of AD-like skin lesions 
every week after administration of Lactobacillus spp. 
 
The dermatitis score of AD-like skin lesions was measured concerning 






Supplementary figure 4. Effect of Lactobacillus spp. on serum IgE levels of 
NC/Nga mice 
 
Blood was obtained from NC/Nga mice at the end of the study. IgE serum levels were 
determined using ELISA. SNUV206 treated group tends to be decreased compared to 
the negative control group in the serum IgE level. Values are shown as mean±SD. N.D 




Supplementary figure 5. Effect of Lactobacillus spp. on lymphoid cell subtypes of NC/Nga mice 
Lactobacillus spp. administration did not alter the population of (A) T and B cell, (B) helper T cell, and cytotoxic T cell in the AD-induced 




Supplementary figure 6. Effect of Lactobacillus spp. on the number of CD25+ cells among the CD3+CD4+ T cell population in NC/Nga 
mice 
 
Percentage of CD25+ cells among the CD3+CD4+ T cell population was investigated. The number of CD25+ cells in the SNUV206 treated 
mice was downregulated compared to the negative group mice while the number of CD25+ cells in the negative group was significantly 
upregulated compared to the naïve group, implying that inflammatory tone may attenuate by treatment of SNUV206 to the AD-induced mice. 
Values are shown as mean±SD. * P < 0.05.
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아토피성 피부염은 피부에서 일어나는 만성 염증질환으로, 피부조직에서 
염증을 일으키고 비염, 천식 등 다른 알레르기 반응이 함께 유발되는 알레
르기 행진의 첫 시작으로써 유아기 때 많이 발생한다. 락토바실러스는 알
레르기 질환을 예방 및 치료한다고 보고되고 있으나, 현재까지는 질 유래 
락토바실러스를 이용한 알레르기 질환의 예방 및 치료에 대한 연구는 아직 
보고된 바가 없다. 이 연구에서는 RBL-2H3 세포, EL4 세포, U266B1 세
포 그리고 RAW 264.7 세포를 사용하여 질 유래 락토바실러스 균주의 항 
알레르기 효과를 실험하였다. 몇 개의 균주들이 베타-헥소스 아미니다아제
(β-hexosaminidase), 인터루킨 4 (IL-4), 인터루킨 5 (IL-5) 그리고 면역
글로불린 E (IgE)의 분비를 억제하였고, 항 염증성 사이토카인인 인터루킨 
10 (IL-10)의 분비를 촉진하였다. 질 유래 락토바실러스 균주의 아토피성 
피부염 치료효과를 실험하기 위해 NC/Nga 마우스 모델이 사용되었다. 질 
유래 락토바실러스 크리스파투스 SNUV206 균주를 처리한 마우스 그룹에
서 아토피성 피부염의 여러 증상이 완화됨을 확인하였다.  결론적으로 본 
연구에서는 알레르기와 관련된 면역 마커들을 측정하여 질 유래 락토바실
러스의 알레르기 반응 억제 능력을 확인하였고, 동물실험을 통해 아토피성 
피부염 증상 완화를 확인하여 질 유래 락토바실러스 SNUV206 균주의 아
토피성 피부염 치료 가능성을 제시하였다. 
주요 단어: 질 유래 균, 락토바실러스 크리스파투스, 알레르기, 아토피성 
피부염 
